drugset / Trial / NCT02303574

Single + Multiple Ascending Dose and Food Effect Study of AZD7986 in Healthy Volunteers, PK, PD and Safety Study

NCT02303574

Phase 1 Completed 89 enrolled AstraZeneca
RandomizedParallel-groupSingle-blindBasic science

Summary

This is a phase I, randomised, single-blind placebo-controlled, 2-part study to assess the safety, tolerability, pharmacokinetics, pharmacodynamics and food effect of single and multiple oral doses of AZD7986 in healthy volunteers

Timeline

Start
2014-12-03
Primary completion
2016-08-03
Completion
2016-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Brensocatib Small molecule 5 mg Oral

Indications

No indication recorded.